Predictive value of indirect bilirubin before neoadjuvant chemoradiotherapy in evaluating prognosis of local advanced rectal cancer patients

doi:10.4251/wjgo.v14.i11.2224

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2057)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

107

WORD

HTML

1082

Figures (1-4)

118

Tables (1-3)

113

Sum=1462

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

183

Download

412

Sum=595

Nov 15, 2022 (publication date) through May 6, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Nov 15, 2022; 14(11): 2224-2237
Published online Nov 15, 2022. doi: 10.4251/wjgo.v14.i11.2224

Full Size Figure Download Figure

Figure 1 Nomograms. A: Overall survival; B: Disease-free survival. OS: Overall survival; DFS: Disease-free survival; nCRT: Neoadjuvant chemoradiotherapy; pre-IBIL: Indirect bilirubin before neoadjuvant chemoradiotherapy; BMI: Body mass index; TRG: Tumor regression grade; pre-CA19-9: Carbohydrate antigen 19-9 before neoadjuvant chemoradiotherapy.

Citation: Li SF, Wei R, Yu GH, Jiang Z. Predictive value of indirect bilirubin before neoadjuvant chemoradiotherapy in evaluating prognosis of local advanced rectal cancer patients. World J Gastrointest Oncol 2022; 14(11): 2224-2237
URL: https://www.wjgnet.com/1948-5204/full/v14/i11/2224.htm
DOI: https://dx.doi.org/10.4251/wjgo.v14.i11.2224